Oncternal Therapeutics, INC
Market Movers (8-K)
Oncternal Therapeutics will be delisted from the Nasdaq Stock Market after announcing a complete workforce reduction and exploring strategic alternatives.
Worse than expected
Oncternal Therapeutics is reducing its workforce and exploring strategic alternatives, incurring approximately $2.4 million in related charges.
Worse than expected